InterVest Co., Ltd. is one of the largest independent venture capital firms in Korea specializing in startups and early stage business investments. As of 2021, the company's Assets Under Management is US$ 1.2 billion. Providing from growth stage equity investment to pre-initial public offering financing through mezzanine and bridge transactions, InterVest typically invests in biotechnology, healthcare, semiconductor, Fintech, block-chain, and many other digital technologies. Since its founding in 1999, InterVest has been an innovator and the most active investor of Korean VC industry: It was Korea’s first VC fund with Foreign LPs (Han-sing Hi-tech Fund I) ('02) and established Korea’s first government-support global Bio Fund ('13) and SE Asia Focused Fund ('17). The company was selected as a "10 Year Consecutive A-rated Venture Capital Investor" by Ministry of SMEs and Startups in Korea.